European Archives - Page 308 of 1289 - European Medical Journal

EMJ Microbiology & Infectious Diseases 6 [Supplement 1] 2025

As the global population of adults aged over 60 years increases rapidly, the burden of infectious respiratory diseases such as COVID-19…

Respiratory Diseases in Adults

According to the WHO, the proportion of the world’s population aged over 60 years will almost double, from 12% to 22%, between 2015–2050…

Computer-Aided Detection Shows Promise for Tuberculosis Screening

Computer-aided detection software for interpreting chest radiographs could play a crucial role in tuberculosis screening.

The word spotlight on a blue background

Spotlight: December 2024

Catch up on all the latest pharmaceutical industry news from the past month, from breakthroughs in gene therapy to promising drug approvals and more.

Risk Factors for Inadequate Bowel Preparation Before Colonoscopy

A comprehensive meta-analysis has identified key risk factors associated with inadequate bowel preparation before colonoscopy.

New Psoriasis Antibody Treatment Shows Exceptional Clinical Results

Across both trial phases, adverse events were primarily mild to moderate, with no drug-related serious incidents reported.

Pharma review of the year 2024

Look back at the key moments from the past year in pharma with three of our former guests, as they highlight key trends, challenges and more.

The latest edition of AMJ Rheumatology

What’s the future of rheumatology? Discover it in AMJ’s latest journal. From how AI is revolutionizing care to the year’s most impactful…

Triple Single-Pill Lowers Blood Pressure Safely in Clinical Trial

New triple single-pill treatment lowers BP effectively and safely, simplifying early hypertension management in clinical practice.

stamp of approval

Eli Lilly’s tirzepatide wins FDA nod for sleep apnea

Eli Lilly’s weight-loss drug tirzepatide has become the first drug for obstructive sleep apnea, a common but serious sleep disorder.